secwatch.observer — SEC 8-K summary
======================================

Issuer:     STRATA Skin Sciences, Inc. (SSKN)
CIK:        0001051514
Form:       8-K
Filed at:   2023-10-30T23:59:59+00:00
Accession:  0001140361-23-050058
Event type: leadership
Sentiment:  neutral
Materiality: 0.75
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bob Moccia steps down as CEO; Dolev Rafaeli appointed President & CEO; reverse split approved
--------------------------------------------------------------------------------

- Bob Moccia resigned as CEO and board member effective Oct 30, 2023; receives 9 months base salary severance, no 2023 bonus.
- Dr. Dolev Rafaeli appointed Vice-Chairman, President, and CEO; 3-year term, base salary $500k, 75% bonus target, option for 1,745,569 shares.
- Shareholders approved reverse stock split of common stock at ratio between 1:5 and 1:25, board to set exact ratio within 6 months.
- CFO Chris Lesovitz receives $142,500 retention bonus for staying through filing of FY2023 10-K.
- All five director nominees elected; advisory votes on executive compensation and frequency (3 years favored) approved.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1051514/000114036123050058/0001140361-23-050058-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1051514/000114036123050058/ef20013534_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-23-050058

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer